Jacques Quilici - Concepedia

Author

Jacques Quilici

Also Known As

J QUILICI, J Quilici, J. Q. Quilici, J. QUILICI, J. Quilici, Jacques Quilici, Mathieu Pankert, Pierre-Emmanuel Morange, Quilici, Jacques

141

Publications

Citations

H-Index

Concepts

All Affiliations

Hôpital de la Timone Inserm Aix-Marseille Université Nutrition, Obésité et Risque Thrombotique Hôpital Laveran

About

Jacques Quilici is an author at Hôpital de la Timone specializing in medicine, cardiovascular disease, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	33	2.7K
2	Public Health	5	5	233
3	Health Sciences	3	3	252
4	Engineering	1	1	82
5	Anesthesia	1	1	22

Jacques Quilici

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study Thomas Cuisset, Pierre Deharo, Jacques Quilici, European Heart Journal	2017	393
High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome T. Cuisset, Corinne Frère, Jacques Quilici, Journal of Thrombosis and Haemostasis Percutaneous Coronary InterventionThrombosisDual Antiplatelet TherapyCardiovascular DiseaseBlood Platelet	2005	367
Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary Stenting Thomas Cuisset, Corinne Frère, Jacques Quilici, Journal of the American College of Cardiology Percutaneous Coronary InterventionThrombosisCardiovascular Disease600-Mg Loading DoseMedicine	2006	343
Comparison of Omeprazole and Pantoprazole Influence on a High 150-mg Clopidogrel Maintenance Dose Thomas Cuisset, Corinne Frère, Jacques Quilici, Journal of the American College of Cardiology MedicinePharmacotherapyPharmacologyPantoprazole Influence	2009	223
Effect of Cytochrome P450 Polymorphisms on Platelet Reactivity After Treatment With Clopidogrel in Acute Coronary Syndrome Corinne Frère, Thomas Cuisset, Pierre‐Emmanuel Morange, The American Journal of Cardiology ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletMedicine	2008	209
ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome Corinne Frère, Thomas Cuisset, Jacques Quilici, Thrombosis and Haemostasis Good Predictive MarkersCoronary Artery DiseaseAcute Myocardial InfarctionAdp-induced Platelet AggregationThrombosis	2007	201
Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders Thomas Cuisset, Corinne Frère, Jacques Quilici, JACC: Cardiovascular Interventions ThrombosisPercutaneous Coronary InterventionCardiovascular DiseasePharmacologyPharmacotherapy	2008	150
Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Thomas Cuisset, Guillaume Cayla, Corinne Frère, EuroIntervention	2009	124
CYP2C192 and 17 Alleles Have a Significant Impact on Platelet Response and Bleeding Risk in Patients Treated With Prasugrel After Acute Coronary Syndrome Thomas Cuisset, Marie Loosveld, Pierre‐Emmanuel Morange, JACC: Cardiovascular Interventions ThrombosisCardiovascular DiseasePlatelet ResponseBlood PlateletHematology	2012	102
Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome Thomas Cuisset, Corinne Frère, Jacques Quilici, Thrombosis Research ThrombopoiesisThrombosisCardiovascular DiseasePlatelet ResponseBlood Platelet	2007	91

Page 1